Thursday, October 19, 2017 4:21:33 PM
Broadcast Date: Tuesday, Oct 24, 2017
Time: 11:00 am EST, 8:00 am PT
REGISTRATION IS FREE
Cell-based immunotherapeutics have expanded the clinical drug repertoire for many diseases and provide immeasurable hope for patients who are intractable to the standard of care treatments. Emboldened by the success of cell therapies, investigators are looking for improved modalities by which to generate novel treatments, as well as enhancing existing processes to improve production efficiencies and therapy efficacy. Join us for this upcoming GEN webinar where we will discuss some of the latest tools and technologies currently being employed to enhance immunotherapy culture conditions.
Who Should Attend:
? Immunotherapy researchers
? Cell therapy production scientists
? Scientists working in process development and biomanufacturing
? Translational research scientists
? Clinical researchers
You Will Learn
? About the latest methodologies and improvements in cell culture conditions that will streamline laboratory and manufacturing workflows.
? How various immune cells are made under good manufacturing practices (GMP) conditions
? About the importance of closed and automated manufacturing technologies
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM